Osteoprotegerin/TNFRSF11B Rekombinanter Antikörper
Osteoprotegerin/TNFRSF11B Rekombinant Antikörper für WB, IHC, ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Ratte
Anwendung
WB, IHC, ELISA
Konjugation
Unkonjugiert
CloneNo.
240168E9
Kat-Nr. : 83506-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
83506-1-PBS bindet in WB, IHC, ELISA Osteoprotegerin/TNFRSF11B und zeigt Reaktivität mit human, Ratten
| Getestete Reaktivität | human, Ratte |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | Osteoprotegerin/TNFRSF11B fusion protein Ag2139 |
| Vollständiger Name | tumor necrosis factor receptor superfamily, member 11b |
| Berechnetes Molekulargewicht | 401 aa, 46 kDa |
| Beobachtetes Molekulargewicht | 56 kDa |
| GenBank-Zugangsnummer | BC030155 |
| Gene symbol | TNFRSF11B |
| Gene ID (NCBI) | 4982 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein A purfication |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Osteoprotegerin (OPG), also known as tumor necrosis factor receptor superfamily member 11B (TNFRSF11B) and osteoclastogenesis inhibitory factor (OCIF), belongs to the tumor necrosis factor (TNF) receptor superfamily. By binding to RANKL, OPG inhibits osteoclastic activity and promotes bone formation. OPG plays a key role in cell survival by inhibiting TRAIL-induced apoptosis. OPG also is involved in vascular biology, fibrosis, immunity, EMT, and the apoptosis of cancer cells (PMID: 35523775).







